NDTP — NDT Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $14.48m
- $14.42m
Annual balance sheet for NDT Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 December 31st | R2009 December 31st | 2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | ARS | ARS | ARS | ARS |
Standards: | USG | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.008 | 0.008 | 0.003 | 0.008 | 0.181 |
Net Total Receivables | 0.101 | 0 | 0.351 | 0.311 | — |
Prepaid Expenses | |||||
Total Current Assets | 0.109 | 0.008 | 0.375 | 0.33 | 0.209 |
Net Property, Plant And Equipment | — | — | — | — | 0.988 |
Total Assets | 0.109 | 0.008 | 0.375 | 0.33 | 1.2 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.125 | 0.01 | 0.388 | 0.401 | 0 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.125 | 0.01 | 0.388 | 0.401 | 0 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.016 | -0.002 | -0.014 | -0.071 | 1.2 |
Total Liabilities & Shareholders' Equity | 0.109 | 0.008 | 0.375 | 0.33 | 1.2 |
Total Common Shares Outstanding |